SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001539215-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 18, 2026 |
| Document | View SEC Filing |
Transactions
22
Total Shares
321,750
Total Value
$9,280,824.02
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sr. VP of IP, CSO | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 22,750 | $36.75 | $836,062.50 | 39,794 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 4,250 | $29.61 | $125,842.50 | 44,044 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 18,000 | $32.20 | $579,600.00 | 62,044 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 5,000 | $27.94 | $139,700.00 | 67,044 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 16, 2026 | Sale | 34,114 | $50.18 | $1,711,840.52 | 32,930 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 16, 2026 | Sale | 15,886 | $50.49 | $802,084.14 | 17,044 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 17, 2026 | Exercise/Conversion | 22,750 | $39.40 | $896,350.00 | 39,794 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 17, 2026 | Exercise/Conversion | 12,250 | $36.75 | $450,187.50 | 52,044 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 17, 2026 | Exercise/Conversion | 15,000 | $38.60 | $579,000.00 | 67,044 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 17, 2026 | Sale | 27,710 | $49.95 | $1,384,114.50 | 39,334 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 17, 2026 | Sale | 22,290 | $50.73 | $1,130,771.70 | 17,044 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 18, 2026 | Exercise/Conversion | 7,250 | $39.40 | $285,650.00 | 24,294 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 18, 2026 | Sale | 6,838 | $49.55 | $338,822.90 | 17,456 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Common Stock | โ | Mar 18, 2026 | Sale | 412 | $50.48 | $20,797.76 | 17,044 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 22,750 | $0.00 | $0.00 | 12,250 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 4,250 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 18,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 15,000 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | Derivative | Mar 17, 2026 | Exercise/Conversion | 22,750 | $0.00 | $0.00 | 7,250 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | Derivative | Mar 17, 2026 | Exercise/Conversion | 12,250 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | Derivative | Mar 17, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 5,000 | Direct | โ | View Details | |
Sr. VP of IP, CSO | Employee Stock Option (Right to Buy) | Derivative | Mar 18, 2026 | Exercise/Conversion | 7,250 | $0.00 | $0.00 | 0 | Direct | โ | View Details |